Effects of ethanol on AMP kinase signaling
乙醇对 AMP 激酶信号传导的影响
基本信息
- 批准号:7264660
- 负责人:
- 金额:$ 31.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-08-01 至 2009-07-31
- 项目状态:已结题
- 来源:
- 关键词:1-Butanol1-Propanol2,4-Dinitrophenol5&apos-AMP-activated protein kinaseAICA ribonucleotideAcetaldehydeAcetatesAcyltransferaseAffectAlcoholic Fatty LiverAlcoholsBindingBinding ProteinsBuffersCalciumCaprylatesCarbonCarnitineCellsChargeCoenzyme AConsensusCultured CellsDNA BindingDUSP1 geneDietDinitrophenolsDominant-Negative MutationEnergy-Generating ResourcesEnzymesEthanolFatty AcidsFatty acid glycerol estersFructoseGenerationsGenesGenetic TranscriptionGlucoseHepaticHepatocyteIonophoresLightLipidsLiverLiver diseasesMAPK14 geneMetabolicMetabolismMetforminMethylene blueMitochondriaMusOligomycinsOxidative StressPPAR alphaPalmitatesPathogenesisPathway interactionsPeroxisome Proliferator-Activated ReceptorsPhosphorylationPhosphotransferasesPropanolsProtein Kinase CRateRattusResponse ElementsRoleRouteSB 203580Saturated Fatty AcidsSignal PathwaySignal TransductionSorbitolSourceStearatesSterolsTestingTriglyceridesUncoupling AgentsUreaadenylate kinasealcohol effectarachidonatebeta-Hydroxybutyratecaprylatefatty acid oxidationfeedinghepatoma cellinhibitor/antagonistinterestkinase inhibitorlipid metabolismliver metabolismlong chain fatty acidnon-alcoholic fatty liverprotein functionsaturated fatsensortranscription factor
项目摘要
DESCRIPTION (provided by applicant): Control of hepatic lipid metabolism is regulated by the transcription factors sterol response element binding protein (SREBP) and peroxisome proliferator activated receptor (PPAR) alpha. Activation of SREBP induces a battery of enzymes involved in lipid synthesis, including acetyI-CoA carboxylase (ACC). The product of ACC, malonyI-CoA, inhibits fatty acid oxidation by inhibiting carnitine palmitoyl acyltransferase, the enzymatic step required for entry of long chain fatty acids into the mitochondrion. Conversely, PPAR activates a battery of genes encoding enzymes involved in the oxidation of fatty acids. Fatty acid synthesis proceeds when there are excess carbon atoms and energy sources, and fatty acid oxidation occurs when energy is needed. AMP kinase (AMPK) has emerged as an important sensor of the energy state and regulator of intermediary metabolism in liver. AMPK inhibits SREBP and ACC activity. Ethanol treatment of cultured cells and of mice activates SREBP and ACC and reduces the abundance and activity of AMPK. We hypothesize that the effect of ethanol on AMPK is central to its other effects on lipid metabolism. To fully understand this effect of ethanol, which may be of fundamental importance in the pathogenesis of alcoholic fatty liver, we will investigate the mechanisms of inhibition of AMPK by ethanol. There are two broad mechanisms we will study: 1) that ethanol, as a source of carbon and reducing equivalents, inhibits the enzyme via increasing the energy charge of the cell or 2) that ethanol or its metabolites alters signaling pathways that impinge on AMPK, such as oxidative stress signaling and alterations in calcium and PKC activity. We will also examine whether AMPK and PPARa are coordinately regulated by ethanol and if the inhibition of AMPK by ethanol is modulated by the presence of saturated fatty acids. These studies will illuminate this interesting new mechanism for ethanol control of liver metabolism and offers potentials for therapy of alcoholic fatty liver. It may also shed light on the pathogenesis of non-alcoholic fatty liver disease.
描述(由申请人提供):控制肝脂质代谢的控制受转录因子固醇反应元件结合蛋白(SREBP)和过氧化物酶体增殖物激活受体(PPAR)alpha的调节。 SREBP的激活诱导一系列参与脂质合成的酶,包括乙酸碳酸盐羧化酶(ACC)。 ACC,Malonyi-COA的产物通过抑制肉碱棕榈酰酰基转移酶抑制脂肪酸氧化,这是将长链脂肪酸进入线粒体所需的酶促步骤。相反,PPAR激活一系列基因,编码涉及脂肪酸氧化的酶。当碳原子和能源过多时,脂肪酸合成会进行,并且在需要能量时会发生脂肪酸氧化。 AMP激酶(AMPK)已成为肝脏中介代谢的能量状态和调节剂的重要传感器。 AMPK抑制SREBP和ACC活性。培养细胞和小鼠的乙醇处理可激活SREBP并降低AMPK的丰度和活性。我们假设乙醇对AMPK的影响对于其对脂质代谢的其他影响至关重要。为了充分了解乙醇的这种作用,这在酒精脂肪肝的发病机理中可能至关重要,我们将研究乙醇抑制AMPK的机制。我们将研究有两种广泛的机制:1)乙醇作为碳的来源和减少等效物的来源,通过增加细胞的能量电荷或2)乙醇或其代谢物可以改变对AMPK的信号通路来抑制酶,例如氧化应激信号传递和PKC活性。我们还将检查AMPK和PPARA是否由乙醇协调调节,以及是否通过饱和脂肪酸的存在调节乙醇对AMPK的抑制。这些研究将阐明这种有趣的新机制,用于控制肝脏代谢,并为酒精脂肪肝的治疗提供了潜力。它还可以阐明非酒精性脂肪肝病的发病机理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID W CRABB其他文献
DAVID W CRABB的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID W CRABB', 18)}}的其他基金
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-ADMIN)
转化研究和不断发展的酒精性肝炎治疗 (TREAT-ADMIN)
- 批准号:
8427520 - 财政年份:2012
- 资助金额:
$ 31.67万 - 项目类别:
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-ADMIN)
转化研究和不断发展的酒精性肝炎治疗 (TREAT-ADMIN)
- 批准号:
9093659 - 财政年份:2012
- 资助金额:
$ 31.67万 - 项目类别:
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-ADMIN)
转化研究和不断发展的酒精性肝炎治疗 (TREAT-ADMIN)
- 批准号:
8544963 - 财政年份:2012
- 资助金额:
$ 31.67万 - 项目类别:
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-ADMIN)
转化研究和不断发展的酒精性肝炎治疗 (TREAT-ADMIN)
- 批准号:
8867961 - 财政年份:2012
- 资助金额:
$ 31.67万 - 项目类别:
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-ADMIN)
转化研究和不断发展的酒精性肝炎治疗 (TREAT-ADMIN)
- 批准号:
9517603 - 财政年份:2012
- 资助金额:
$ 31.67万 - 项目类别:
SBIRT Implementation in the Indiana University Educational Innovations Project
SBIRT 在印第安纳大学教育创新项目中的实施
- 批准号:
8503464 - 财政年份:2009
- 资助金额:
$ 31.67万 - 项目类别:
SBIRT Implementation in the Indiana University Educational Innovations Project
SBIRT 在印第安纳大学教育创新项目中的实施
- 批准号:
8109883 - 财政年份:2009
- 资助金额:
$ 31.67万 - 项目类别:
SBIRT Implementation in the Indiana University Educational Innovations Project
SBIRT 在印第安纳大学教育创新项目中的实施
- 批准号:
7918288 - 财政年份:2009
- 资助金额:
$ 31.67万 - 项目类别:
SBIRT Implementation in the Indiana University Educational Innovations Project
SBIRT 在印第安纳大学教育创新项目中的实施
- 批准号:
8290981 - 财政年份:2009
- 资助金额:
$ 31.67万 - 项目类别:
SBIRT Implementation in the Indiana University Educational Innovations Project
SBIRT 在印第安纳大学教育创新项目中的实施
- 批准号:
7931969 - 财政年份:2009
- 资助金额:
$ 31.67万 - 项目类别:
相似国自然基金
1-二甲氨基-2-丙醇强化胺溶剂吸收CO2机制及动力学研究
- 批准号:22208017
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
1-二甲氨基-2-丙醇强化胺溶剂吸收CO2机制及动力学研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
一个新的环丙酮等价物的合成应用
- 批准号:20872176
- 批准年份:2008
- 资助金额:33.0 万元
- 项目类别:面上项目
镓参与的有机合成反应
- 批准号:20702046
- 批准年份:2007
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Engineer Escherichia coli for 1-propanol production by integrating novel biotechnological and bioprocessing strategies
通过整合新颖的生物技术和生物加工策略,改造大肠杆菌以生产 1-丙醇
- 批准号:
RGPIN-2014-05568 - 财政年份:2018
- 资助金额:
$ 31.67万 - 项目类别:
Discovery Grants Program - Individual
Process optimisation of 2,3-epoxy-1-propanol for downstream speciality chemical production.
用于下游特种化学品生产的 2,3-环氧-1-丙醇的工艺优化。
- 批准号:
132524 - 财政年份:2017
- 资助金额:
$ 31.67万 - 项目类别:
Feasibility Studies
Engineer Escherichia coli for 1-propanol production by integrating novel biotechnological and bioprocessing strategies
通过整合新颖的生物技术和生物加工策略,改造大肠杆菌以生产 1-丙醇
- 批准号:
RGPIN-2014-05568 - 财政年份:2017
- 资助金额:
$ 31.67万 - 项目类别:
Discovery Grants Program - Individual
Engineer Escherichia coli for 1-propanol production by integrating novel biotechnological and bioprocessing strategies
通过整合新颖的生物技术和生物加工策略,改造大肠杆菌以生产 1-丙醇
- 批准号:
RGPIN-2014-05568 - 财政年份:2016
- 资助金额:
$ 31.67万 - 项目类别:
Discovery Grants Program - Individual
Asymmetric synthesis of highly functionalized lactones and lactams using a chiral Bronsted acid
使用手性布朗斯台德酸不对称合成高官能化内酯和内酰胺
- 批准号:
8958040 - 财政年份:2015
- 资助金额:
$ 31.67万 - 项目类别: